Osteoblast/Osteoclast Development and Function in Osteogenesis Imperfecta - Osteogenesis Imperfecta - page 46

[20] Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S,
Reginato AM, et al. LDL receptor-related protein 5 (LRP5)
affects bone accrual and eye development. Cell 2001;107(4):
513-23.
[21] Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N,
Robinson DR, et al. Lrp5 functions in bone to regulate bone
mass. Nat Med 2011;17(6):684-91.
[22] Blair HC, Robinson LJ, Zaidi M. Osteoclast signalling path-
ways. Biochem Biophys Res Commun 2005;328(3):728-38.
[23] Roodman GD. Regulation of osteoclast differentiation. Ann N
Y Acad Sci 2006;1068:100-9.
[24] Barrow AD, Raynal N, Andersen TL, Slatter DA, Bihan D,
Pugh N, et al. OSCAR is a collagen receptor that costimulates
osteoclastogenesis in DAP12-deicient humans and mice. J Clin
Invest 2011;121(9):3505-16.
[25] Bernhardt A, Thieme S, Domaschke H, Springer A, Rosen-
Wolff A, Gelinsky M. Crosstalk of osteoblast and osteoclast
precursors on mineralized collagen - towards an in vitro
model for bone remodeling. J Biomed Mater Res A 2010;95(3):
848-56.
[26] Helfrich MH, Nesbitt SA, Lakkakorpi PT, Barnes MJ,
Bodary SC, Shankar G, et al. Beta 1 integrins and osteoclast
function: involvement in collagen recognition and bone resorp-
tion. Bone 1996;19(4):317-28.
[27] Nemeth K, Schoppet M, Al-Fakhri N, Helas S, Jessberger R,
Hofbauer LC, et al. The role of osteoclast-associated receptor in
osteoimmunology. J Immunol 2011;186(1):13-18.
[28] Scott JE, Haigh M, Nusgens B, Lapiere CM. Proteoglycan: col-
lagen interactions in dermatosparactic skin and tendon. An
electron histochemical study using cupromeronic blue in a crit-
ical electrolyte concentration method. Matrix 1989;9(6):437-42.
[29] Valli M, Leonardi L, Strocchi R, Tenni R, Guizzardi S, Ruggeri A,
et al. “In vitro” ibril formation of type I collagen from different
sources: biochemical and morphological aspects. Connect Tissue
Res 1986;15(4):235-44.
[30] Banos CC, Thomas AH, Kuo CK. Collagen ibrillogenesis in
tendon development: current models and regulation of ibril
assembly. Birth Defects Res. C Embryo Today 2008;84(3):228-44.
[31] Wiestner M, Krieg T, Horlein D, Glanville RW, Fietzek P,
Muller PK. Inhibiting effect of procollagen peptides on
collagen biosynthesis in ibroblast cultures. J Biol Chem
1979;254(15):7016-23.
[32] Horlein D, McPherson J, Goh SH, Bornstein P. Regulation of
protein synthesis: translational control by procollagen-derived
fragments. Proc Natl Acad Sci USA 1981;78(10):6163-7.
[33] Pinnell SR. Regulation of collagen synthesis. J Invest Dermatol
1982;79(Suppl. 1):73s-76ss.
[34] McPherson JM, Horlein D, Abbott-Brown D, Bornstein P.
Inhibition of protein synthesis in vitro by procollagen-derived
fragments is associated with changes in protein phosphoryla-
tion. J Biol Chem 1982;257(15):8557-60.
[35] Goldenberg R, Fine RE. Generalized inhibition of cell-free
translation by the amino-terminal propeptide of chick type I
procollagen. Biochim Biophys Acta 1985;826(2-3):101-7.
[36] Card L, Henderson N, Zhang Y, Bornstein P, Bradshaw AD.
Expression in SPARC-null mice of collagen type I lacking
the globular domain of the alpha1(I) N-propeptide results in
abdominal hernias and loss of dermal collagen. Matrix Biol
2010;29(7):559-64.
[37] Fouser L, Sage EH, Clark J, Bornstein P. Feedback regulation of
collagen gene expression: a Trojan horse approach. Proc Natl
Acad Sci USA 1991;88(22):10158-62.
[38] Oganesian A, Au S, Horst JA, Holzhausen LC, Macy AJ, Pace
JM, et al. The NH2-terminal propeptide of type I procolla-
gen acts intracellularly to modulate cell function. J Biol Chem
2006;281(50):38507-18.

[39] Coletta RD, Almeida OP, Ferreira LR, Reynolds MA, Sauk JJ.
Increase in expression of Hsp47 and collagen in hereditary gin-
gival ibromatosis is modulated by stress and terminal procol-
lagen N-propeptides. Connect Tissue Res 1999;40(4):237-49.
[40] Katayama K, Armendariz-Borunda J, Raghow R, Kang AH,
Seyer JM. A pentapeptide from type I procollagen promotes
extracellular matrix production. J Biol Chem 1993;268(14):9941-4.
[41] Weston SA, Hulmes DJ, Mould AP, Watson RB, Humphries MJ.
Identiication of integrin alpha 2 beta 1 as cell surface recep-
tor for the carboxyl-terminal propeptide of type I procollagen.
J Biol Chem 1994;269(33):20982-86.
[42] Davies D, Tuckwell DS, Calderwood DA, Weston SA,
Takigawa M, Humphries MJ. Molecular characterisation of
integrin-procollagen C-propeptide interactions. Eur J Biochem
1997;246(2):274-82.
[43] Bhattacharyya-Pakrasi M, Dickeson SK, Santoro SA. Alpha2beta1
integrin recognition of the carboxyl-terminal propeptide of type
I procollagen: integrin recognition and feed-back regulation of
matrix biosynthesis are mediated by distinct sequences. Matrix
Biol 1998;17(3):223-32.
[44] Engelholm LH, Ingvarsen S, Jurgensen HJ, Hillig T, Madsen
DH, Nielsen BS, et al. The collagen receptor uPARAP / Endo180.
Front Biosci 2009;14:2103-14.
[45] Labrador JP, Azcoitia V, Tuckermann J, Lin C, Olaso E, Manes S,
et al. The collagen receptor DDR2 regulates proliferation and its
elimination leads to dwarism. EMBO Rep 2001;2(5):446-52.
[46] Jikko A, Harris SE, Chen D, Mendrick DL, Damsky CH.
Collagen integrin receptors regulate early osteoblast differenti-
ation induced by BMP-2. J Bone Miner Res 1999;14(7):1075-83.
[47] Allori AC, Sailon AM, Warren SM. Biological basis of bone for-
mation, remodeling, and repair - part II: extracellular matrix.
Tissue Eng Part B Rev 2008;14(3):275-83.
[48] Horton MA. Interactions of connective tissue cells with the
extracellular matrix. Bone 1995;17(Suppl. 2):51S-53SS.
[49] Solursh M. Extracellular matrix and cell surface as determi-
nants of connective tissue differentiation. Am J Med Genet
1989;34(1):30-4.
[50] Alford AI, Hankenson KD. Matricellular proteins: extracellular
modulators of bone development, remodeling, and regenera-
tion. Bone 2006;38(6):749-57.
[51] Gentili C, Cancedda R. Cartilage and bone extracellular matrix.
Curr Pharm Des 2009;15(12):1334-48.
[52] Fisher LW. The nature of proteoglycans of bone Butler TW,
editor. The chemistry and biology of mineralized tissues.
Birmingham, AL: EBSCO Media Inc.; 1985. p. 188-96.
[53] Fleischmajer R, Fisher LW, MacDonald ED, Jacobs Jr. L, Perlish JS,
Termine JD. Decorin interacts with ibrillar collagen of embryonic
and adult human skin. J Struct Biol 1991;106(1):82-90.
[54] Kolb M, Margetts PJ, Sime PJ, Gauldie J. Proteoglycans deco-
rin and biglycan differentially modulate TGF-beta-mediated
ibrotic responses in the lung. Am J Physiol - Lung Cell Mol
Physiol 2001;280(6):L1327-34.
[55] Fedarko NS, Termine JD, Young MF, Robey PG. Temporal regu-
lation of hyaluronan and proteoglycan metabolism by human
bone cells in vitro. J Biol Chem 1990;265(21):12200-09.
[56] Sillence DO. Osteogenesis imperfecta nosology and genetics.
Ann N Y Acad Sci 1988;543:1-15.
[57] Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD,
Milgrom S, et al. Consortium for osteogenesis imperfecta muta-
tions in the helical domain of type I collagen: regions rich in
lethal mutations align with collagen binding sites for integrins
and proteoglycans. Hum Mutat 2007;28(3):209-21.
[58] Byers PH. Brittle bones - fragile molecules: disorders of collagen
gene structure and expression. Trends Genet 1990;6(9):293-300.
[59] Willing MC, Deschenes SP, Slayton RL, Roberts EJ. Premature
chain termination is a unifying mechanism for COL1A1 null